nodes	percent_of_prediction	percent_of_DWPC	metapath
Disulfiram—CYP3A5—Paclitaxel—ovarian cancer	0.127	0.217	CbGbCtD
Disulfiram—CYP3A4—Topotecan—ovarian cancer	0.0997	0.171	CbGbCtD
Disulfiram—CYP3A5—Docetaxel—ovarian cancer	0.0915	0.157	CbGbCtD
Disulfiram—CYP2C9—Paclitaxel—ovarian cancer	0.0848	0.145	CbGbCtD
Disulfiram—CYP3A4—Vinorelbine—ovarian cancer	0.0702	0.12	CbGbCtD
Disulfiram—CYP3A4—Paclitaxel—ovarian cancer	0.0493	0.0845	CbGbCtD
Disulfiram—CYP3A4—Docetaxel—ovarian cancer	0.0357	0.0611	CbGbCtD
Disulfiram—CYP3A4—Doxorubicin—ovarian cancer	0.0266	0.0455	CbGbCtD
Disulfiram—Polyneuropathy—Paclitaxel—ovarian cancer	0.0108	0.0341	CcSEcCtD
Disulfiram—Neuropathy peripheral—Altretamine—ovarian cancer	0.0106	0.0335	CcSEcCtD
Disulfiram—Dermatitis atopic—Chlorambucil—ovarian cancer	0.00931	0.0293	CcSEcCtD
Disulfiram—Neuritis—Chlorambucil—ovarian cancer	0.00923	0.0291	CcSEcCtD
Disulfiram—Polyneuropathy—Docetaxel—ovarian cancer	0.00918	0.0289	CcSEcCtD
Disulfiram—Dermatitis atopic—Melphalan—ovarian cancer	0.00812	0.0256	CcSEcCtD
Disulfiram—Tingling sensation—Melphalan—ovarian cancer	0.00747	0.0235	CcSEcCtD
Disulfiram—ALDH2—myometrium—ovarian cancer	0.00653	0.0861	CbGeAlD
Disulfiram—Numbness—Vinorelbine—ovarian cancer	0.00633	0.0199	CcSEcCtD
Disulfiram—Polyneuropathy—Epirubicin—ovarian cancer	0.00619	0.0195	CcSEcCtD
Disulfiram—DBH—female reproductive system—ovarian cancer	0.00609	0.0803	CbGeAlD
Disulfiram—Hepatic necrosis—Paclitaxel—ovarian cancer	0.00607	0.0191	CcSEcCtD
Disulfiram—Sensory loss—Vinorelbine—ovarian cancer	0.00606	0.0191	CcSEcCtD
Disulfiram—Fatigue—Altretamine—ovarian cancer	0.00596	0.0188	CcSEcCtD
Disulfiram—Neuropathy—Topotecan—ovarian cancer	0.00576	0.0181	CcSEcCtD
Disulfiram—DBH—bone marrow—ovarian cancer	0.00575	0.0758	CbGeAlD
Disulfiram—Polyneuropathy—Doxorubicin—ovarian cancer	0.00573	0.018	CcSEcCtD
Disulfiram—Neuropathy—Melphalan—ovarian cancer	0.00564	0.0178	CcSEcCtD
Disulfiram—ALDH2—uterine cervix—ovarian cancer	0.00508	0.067	CbGeAlD
Disulfiram—Asthenia—Altretamine—ovarian cancer	0.00496	0.0156	CcSEcCtD
Disulfiram—Eruption—Docetaxel—ovarian cancer	0.00486	0.0153	CcSEcCtD
Disulfiram—ALDH2—decidua—ovarian cancer	0.00484	0.0638	CbGeAlD
Disulfiram—Dermatitis atopic—Paclitaxel—ovarian cancer	0.00477	0.015	CcSEcCtD
Disulfiram—Neuritis—Paclitaxel—ovarian cancer	0.00473	0.0149	CcSEcCtD
Disulfiram—ALDH2—endometrium—ovarian cancer	0.0046	0.0606	CbGeAlD
Disulfiram—Dizziness—Altretamine—ovarian cancer	0.00457	0.0144	CcSEcCtD
Disulfiram—Tingling sensation—Paclitaxel—ovarian cancer	0.00439	0.0138	CcSEcCtD
Disulfiram—ALDH2—gonad—ovarian cancer	0.00426	0.0562	CbGeAlD
Disulfiram—Hepatic failure—Vinorelbine—ovarian cancer	0.00424	0.0133	CcSEcCtD
Disulfiram—ALDH2—uterus—ovarian cancer	0.00424	0.0558	CbGeAlD
Disulfiram—Pain—Carboplatin—ovarian cancer	0.00409	0.0129	CcSEcCtD
Disulfiram—Sensory loss—Paclitaxel—ovarian cancer	0.00407	0.0128	CcSEcCtD
Disulfiram—Tenderness—Paclitaxel—ovarian cancer	0.00405	0.0127	CcSEcCtD
Disulfiram—Dermatitis atopic—Docetaxel—ovarian cancer	0.00404	0.0127	CcSEcCtD
Disulfiram—Neuritis—Docetaxel—ovarian cancer	0.00401	0.0126	CcSEcCtD
Disulfiram—ALDH2—female reproductive system—ovarian cancer	0.00381	0.0502	CbGeAlD
Disulfiram—Neuropathy peripheral—Chlorambucil—ovarian cancer	0.00378	0.0119	CcSEcCtD
Disulfiram—Jaundice—Chlorambucil—ovarian cancer	0.00376	0.0118	CcSEcCtD
Disulfiram—ALDH2—bone marrow—ovarian cancer	0.00359	0.0474	CbGeAlD
Disulfiram—DBH—lymph node—ovarian cancer	0.00356	0.047	CbGeAlD
Disulfiram—ALDH2—female gonad—ovarian cancer	0.00346	0.0457	CbGeAlD
Disulfiram—ALDH2—vagina—ovarian cancer	0.00344	0.0454	CbGeAlD
Disulfiram—Neuropathy peripheral—Topotecan—ovarian cancer	0.00336	0.0106	CcSEcCtD
Disulfiram—Neuropathy—Paclitaxel—ovarian cancer	0.00331	0.0104	CcSEcCtD
Disulfiram—Neuropathy peripheral—Melphalan—ovarian cancer	0.00329	0.0104	CcSEcCtD
Disulfiram—Eruption—Epirubicin—ovarian cancer	0.00328	0.0103	CcSEcCtD
Disulfiram—Optic neuritis—Epirubicin—ovarian cancer	0.00328	0.0103	CcSEcCtD
Disulfiram—Jaundice—Melphalan—ovarian cancer	0.00328	0.0103	CcSEcCtD
Disulfiram—ALDH2—testis—ovarian cancer	0.00307	0.0405	CbGeAlD
Disulfiram—Hypoaesthesia—Topotecan—ovarian cancer	0.00307	0.00965	CcSEcCtD
Disulfiram—Optic neuritis—Doxorubicin—ovarian cancer	0.00304	0.00956	CcSEcCtD
Disulfiram—Eruption—Doxorubicin—ovarian cancer	0.00304	0.00956	CcSEcCtD
Disulfiram—Hepatitis—Melphalan—ovarian cancer	0.00302	0.0095	CcSEcCtD
Disulfiram—Neuropathy peripheral—Vinorelbine—ovarian cancer	0.00288	0.00906	CcSEcCtD
Disulfiram—DBH—Amine-derived hormones—SLC5A5—ovarian cancer	0.00285	0.128	CbGpPWpGaD
Disulfiram—Eye pain—Paclitaxel—ovarian cancer	0.00284	0.00894	CcSEcCtD
Disulfiram—Neuropathy—Docetaxel—ovarian cancer	0.00281	0.00884	CcSEcCtD
Disulfiram—DBH—Monoamine Transport—RBL2—ovarian cancer	0.00279	0.125	CbGpPWpGaD
Disulfiram—Dermatitis atopic—Epirubicin—ovarian cancer	0.00273	0.00858	CcSEcCtD
Disulfiram—Neuritis—Epirubicin—ovarian cancer	0.0027	0.00851	CcSEcCtD
Disulfiram—Hypoaesthesia—Vinorelbine—ovarian cancer	0.00262	0.00826	CcSEcCtD
Disulfiram—DBH—Monoamine Transport—PVRL2—ovarian cancer	0.00254	0.114	CbGpPWpGaD
Disulfiram—Dermatitis atopic—Doxorubicin—ovarian cancer	0.00252	0.00794	CcSEcCtD
Disulfiram—Neuritis—Doxorubicin—ovarian cancer	0.0025	0.00787	CcSEcCtD
Disulfiram—Hepatic failure—Docetaxel—ovarian cancer	0.00242	0.00761	CcSEcCtD
Disulfiram—CYP3A5—uterine cervix—ovarian cancer	0.00229	0.0303	CbGeAlD
Disulfiram—ALDH2—lymph node—ovarian cancer	0.00223	0.0294	CbGeAlD
Disulfiram—Fatigue—Chlorambucil—ovarian cancer	0.00212	0.00667	CcSEcCtD
Disulfiram—Pain—Chlorambucil—ovarian cancer	0.0021	0.00662	CcSEcCtD
Disulfiram—Paraesthesia—Topotecan—ovarian cancer	0.00197	0.00619	CcSEcCtD
Disulfiram—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00194	0.00609	CcSEcCtD
Disulfiram—Paraesthesia—Melphalan—ovarian cancer	0.00192	0.00606	CcSEcCtD
Disulfiram—Neuropathy—Epirubicin—ovarian cancer	0.00189	0.00597	CcSEcCtD
Disulfiram—Fatigue—Topotecan—ovarian cancer	0.00189	0.00594	CcSEcCtD
Disulfiram—Pain—Topotecan—ovarian cancer	0.00187	0.00589	CcSEcCtD
Disulfiram—Fatigue—Melphalan—ovarian cancer	0.00185	0.00582	CcSEcCtD
Disulfiram—Pain—Melphalan—ovarian cancer	0.00183	0.00577	CcSEcCtD
Disulfiram—Asthenia—Chlorambucil—ovarian cancer	0.00176	0.00555	CcSEcCtD
Disulfiram—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00176	0.00555	CcSEcCtD
Disulfiram—Neuropathy—Doxorubicin—ovarian cancer	0.00175	0.00552	CcSEcCtD
Disulfiram—CYP2C9—female reproductive system—ovarian cancer	0.00169	0.0223	CbGeAlD
Disulfiram—Paraesthesia—Vinorelbine—ovarian cancer	0.00168	0.00529	CcSEcCtD
Disulfiram—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00164	0.00517	CcSEcCtD
Disulfiram—Jaundice—Docetaxel—ovarian cancer	0.00163	0.00514	CcSEcCtD
Disulfiram—Hepatic failure—Epirubicin—ovarian cancer	0.00163	0.00513	CcSEcCtD
Disulfiram—Eye pain—Epirubicin—ovarian cancer	0.00162	0.00511	CcSEcCtD
Disulfiram—Fatigue—Vinorelbine—ovarian cancer	0.00161	0.00508	CcSEcCtD
Disulfiram—CYP2E1—female reproductive system—ovarian cancer	0.0016	0.0211	CbGeAlD
Disulfiram—Pain—Vinorelbine—ovarian cancer	0.0016	0.00504	CcSEcCtD
Disulfiram—Asthenia—Topotecan—ovarian cancer	0.00157	0.00494	CcSEcCtD
Disulfiram—CYP3A5—female gonad—ovarian cancer	0.00156	0.0206	CbGeAlD
Disulfiram—CYP3A5—vagina—ovarian cancer	0.00156	0.0205	CbGeAlD
Disulfiram—Asthenia—Melphalan—ovarian cancer	0.00154	0.00484	CcSEcCtD
Disulfiram—Hepatic failure—Doxorubicin—ovarian cancer	0.00151	0.00475	CcSEcCtD
Disulfiram—Hepatitis—Docetaxel—ovarian cancer	0.0015	0.00473	CcSEcCtD
Disulfiram—Eye pain—Doxorubicin—ovarian cancer	0.0015	0.00473	CcSEcCtD
Disulfiram—Hypoaesthesia—Docetaxel—ovarian cancer	0.0015	0.00471	CcSEcCtD
Disulfiram—Dizziness—Topotecan—ovarian cancer	0.00145	0.00456	CcSEcCtD
Disulfiram—Rash—Topotecan—ovarian cancer	0.00138	0.00434	CcSEcCtD
Disulfiram—Headache—Topotecan—ovarian cancer	0.00137	0.00432	CcSEcCtD
Disulfiram—Rash—Melphalan—ovarian cancer	0.00135	0.00425	CcSEcCtD
Disulfiram—Asthenia—Vinorelbine—ovarian cancer	0.00134	0.00423	CcSEcCtD
Disulfiram—CYP2E1—testis—ovarian cancer	0.00129	0.0171	CbGeAlD
Disulfiram—CYP3A4—female reproductive system—ovarian cancer	0.00129	0.017	CbGeAlD
Disulfiram—Dizziness—Vinorelbine—ovarian cancer	0.00124	0.0039	CcSEcCtD
Disulfiram—Rash—Vinorelbine—ovarian cancer	0.00118	0.00372	CcSEcCtD
Disulfiram—Headache—Vinorelbine—ovarian cancer	0.00117	0.00369	CcSEcCtD
Disulfiram—Paraesthesia—Paclitaxel—ovarian cancer	0.00113	0.00356	CcSEcCtD
Disulfiram—Drowsiness—Epirubicin—ovarian cancer	0.00113	0.00355	CcSEcCtD
Disulfiram—Somnolence—Paclitaxel—ovarian cancer	0.00112	0.00352	CcSEcCtD
Disulfiram—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00111	0.00348	CcSEcCtD
Disulfiram—Jaundice—Epirubicin—ovarian cancer	0.0011	0.00346	CcSEcCtD
Disulfiram—Fatigue—Paclitaxel—ovarian cancer	0.00109	0.00342	CcSEcCtD
Disulfiram—Pain—Paclitaxel—ovarian cancer	0.00108	0.00339	CcSEcCtD
Disulfiram—Drowsiness—Doxorubicin—ovarian cancer	0.00104	0.00329	CcSEcCtD
Disulfiram—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.00102	0.00322	CcSEcCtD
Disulfiram—Jaundice—Doxorubicin—ovarian cancer	0.00102	0.00321	CcSEcCtD
Disulfiram—Hepatitis—Epirubicin—ovarian cancer	0.00101	0.00319	CcSEcCtD
Disulfiram—Hypoaesthesia—Epirubicin—ovarian cancer	0.00101	0.00317	CcSEcCtD
Disulfiram—Paraesthesia—Docetaxel—ovarian cancer	0.000959	0.00302	CcSEcCtD
Disulfiram—Somnolence—Docetaxel—ovarian cancer	0.000949	0.00299	CcSEcCtD
Disulfiram—Hepatitis—Doxorubicin—ovarian cancer	0.000938	0.00295	CcSEcCtD
Disulfiram—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000933	0.00294	CcSEcCtD
Disulfiram—Fatigue—Docetaxel—ovarian cancer	0.00092	0.0029	CcSEcCtD
Disulfiram—Pain—Docetaxel—ovarian cancer	0.000913	0.00287	CcSEcCtD
Disulfiram—Asthenia—Paclitaxel—ovarian cancer	0.000904	0.00284	CcSEcCtD
Disulfiram—Dizziness—Paclitaxel—ovarian cancer	0.000833	0.00262	CcSEcCtD
Disulfiram—Rash—Paclitaxel—ovarian cancer	0.000794	0.0025	CcSEcCtD
Disulfiram—Headache—Paclitaxel—ovarian cancer	0.000789	0.00248	CcSEcCtD
Disulfiram—ALDH2—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000785	0.0352	CbGpPWpGaD
Disulfiram—Asthenia—Docetaxel—ovarian cancer	0.000766	0.00241	CcSEcCtD
Disulfiram—Dizziness—Docetaxel—ovarian cancer	0.000706	0.00222	CcSEcCtD
Disulfiram—Rash—Docetaxel—ovarian cancer	0.000673	0.00212	CcSEcCtD
Disulfiram—Headache—Docetaxel—ovarian cancer	0.000669	0.00211	CcSEcCtD
Disulfiram—Paraesthesia—Epirubicin—ovarian cancer	0.000647	0.00204	CcSEcCtD
Disulfiram—Somnolence—Epirubicin—ovarian cancer	0.00064	0.00202	CcSEcCtD
Disulfiram—Fatigue—Epirubicin—ovarian cancer	0.000621	0.00195	CcSEcCtD
Disulfiram—Pain—Epirubicin—ovarian cancer	0.000616	0.00194	CcSEcCtD
Disulfiram—Paraesthesia—Doxorubicin—ovarian cancer	0.000598	0.00188	CcSEcCtD
Disulfiram—Somnolence—Doxorubicin—ovarian cancer	0.000592	0.00186	CcSEcCtD
Disulfiram—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	0.000582	0.0261	CbGpPWpGaD
Disulfiram—Fatigue—Doxorubicin—ovarian cancer	0.000574	0.00181	CcSEcCtD
Disulfiram—ALDH2—Transmission across Chemical Synapses—NSF—ovarian cancer	0.000572	0.0256	CbGpPWpGaD
Disulfiram—Pain—Doxorubicin—ovarian cancer	0.00057	0.00179	CcSEcCtD
Disulfiram—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	0.00053	0.0237	CbGpPWpGaD
Disulfiram—Asthenia—Epirubicin—ovarian cancer	0.000517	0.00163	CcSEcCtD
Disulfiram—ALDH2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000515	0.0231	CbGpPWpGaD
Disulfiram—Asthenia—Doxorubicin—ovarian cancer	0.000478	0.0015	CcSEcCtD
Disulfiram—Dizziness—Epirubicin—ovarian cancer	0.000476	0.0015	CcSEcCtD
Disulfiram—Rash—Epirubicin—ovarian cancer	0.000454	0.00143	CcSEcCtD
Disulfiram—Headache—Epirubicin—ovarian cancer	0.000451	0.00142	CcSEcCtD
Disulfiram—Dizziness—Doxorubicin—ovarian cancer	0.000441	0.00139	CcSEcCtD
Disulfiram—ALDH2—Neuronal System—NSF—ovarian cancer	0.000439	0.0196	CbGpPWpGaD
Disulfiram—Rash—Doxorubicin—ovarian cancer	0.00042	0.00132	CcSEcCtD
Disulfiram—Headache—Doxorubicin—ovarian cancer	0.000417	0.00131	CcSEcCtD
Disulfiram—DBH—Amino acid and derivative metabolism—SLC5A5—ovarian cancer	0.000397	0.0178	CbGpPWpGaD
Disulfiram—CYP2E1—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000382	0.0171	CbGpPWpGaD
Disulfiram—CYP3A5—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000382	0.0171	CbGpPWpGaD
Disulfiram—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	0.000353	0.0158	CbGpPWpGaD
Disulfiram—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	0.000349	0.0157	CbGpPWpGaD
Disulfiram—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.000316	0.0142	CbGpPWpGaD
Disulfiram—CYP3A5—Irinotecan Pathway—APC—ovarian cancer	0.000313	0.014	CbGpPWpGaD
Disulfiram—ALDH2—Biological oxidations—CYP1B1—ovarian cancer	0.000273	0.0122	CbGpPWpGaD
Disulfiram—CYP2C9—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000269	0.0121	CbGpPWpGaD
Disulfiram—DBH—Metabolism—NME2—ovarian cancer	0.000241	0.0108	CbGpPWpGaD
Disulfiram—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000224	0.0101	CbGpPWpGaD
Disulfiram—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000214	0.00959	CbGpPWpGaD
Disulfiram—CYP2E1—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000204	0.00915	CbGpPWpGaD
Disulfiram—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	0.000201	0.00899	CbGpPWpGaD
Disulfiram—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000177	0.00795	CbGpPWpGaD
Disulfiram—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000173	0.00775	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—NME2—ovarian cancer	0.000167	0.00747	CbGpPWpGaD
Disulfiram—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000165	0.0074	CbGpPWpGaD
Disulfiram—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000165	0.00738	CbGpPWpGaD
Disulfiram—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000163	0.0073	CbGpPWpGaD
Disulfiram—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000163	0.00728	CbGpPWpGaD
Disulfiram—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000158	0.00709	CbGpPWpGaD
Disulfiram—DBH—Metabolism—CYTB—ovarian cancer	0.000155	0.00694	CbGpPWpGaD
Disulfiram—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000151	0.00675	CbGpPWpGaD
Disulfiram—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	0.000146	0.00653	CbGpPWpGaD
Disulfiram—DBH—Metabolism—PPP1CC—ovarian cancer	0.000135	0.00607	CbGpPWpGaD
Disulfiram—DBH—Metabolism—BRIP1—ovarian cancer	0.000135	0.00607	CbGpPWpGaD
Disulfiram—CYP2C9—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.000134	0.00602	CbGpPWpGaD
Disulfiram—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000134	0.006	CbGpPWpGaD
Disulfiram—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000134	0.00598	CbGpPWpGaD
Disulfiram—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000116	0.0052	CbGpPWpGaD
Disulfiram—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000115	0.00514	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—CYTB—ovarian cancer	0.000107	0.00481	CbGpPWpGaD
Disulfiram—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000104	0.00467	CbGpPWpGaD
Disulfiram—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	9.94e-05	0.00445	CbGpPWpGaD
Disulfiram—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	9.48e-05	0.00424	CbGpPWpGaD
Disulfiram—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	9.42e-05	0.00422	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—BRIP1—ovarian cancer	9.39e-05	0.00421	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—PPP1CC—ovarian cancer	9.39e-05	0.00421	CbGpPWpGaD
Disulfiram—DBH—Metabolism—YAP1—ovarian cancer	9.09e-05	0.00407	CbGpPWpGaD
Disulfiram—ALDH2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.74e-05	0.00347	CbGpPWpGaD
Disulfiram—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	7.66e-05	0.00343	CbGpPWpGaD
Disulfiram—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	7.56e-05	0.00339	CbGpPWpGaD
Disulfiram—DBH—Metabolism—FASN—ovarian cancer	7.41e-05	0.00332	CbGpPWpGaD
Disulfiram—DBH—Metabolism—SLC5A5—ovarian cancer	7.29e-05	0.00326	CbGpPWpGaD
Disulfiram—CYP2E1—Biological oxidations—CYP1B1—ovarian cancer	7.11e-05	0.00319	CbGpPWpGaD
Disulfiram—CYP3A5—Biological oxidations—CYP1B1—ovarian cancer	7.1e-05	0.00318	CbGpPWpGaD
Disulfiram—DBH—Metabolism—SLC2A1—ovarian cancer	7.04e-05	0.00315	CbGpPWpGaD
Disulfiram—CYP2E1—Metapathway biotransformation—CYP1B1—ovarian cancer	7.01e-05	0.00314	CbGpPWpGaD
Disulfiram—CYP3A5—Metapathway biotransformation—CYP1B1—ovarian cancer	7e-05	0.00313	CbGpPWpGaD
Disulfiram—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—ovarian cancer	6.89e-05	0.00309	CbGpPWpGaD
Disulfiram—DBH—Metabolism—CYP1B1—ovarian cancer	6.75e-05	0.00302	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—YAP1—ovarian cancer	6.3e-05	0.00282	CbGpPWpGaD
Disulfiram—ALDH2—Transmission across Chemical Synapses—HRAS—ovarian cancer	6.22e-05	0.00279	CbGpPWpGaD
Disulfiram—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	6.21e-05	0.00278	CbGpPWpGaD
Disulfiram—DBH—Metabolism—PPP2R1A—ovarian cancer	5.98e-05	0.00268	CbGpPWpGaD
Disulfiram—ALDH2—Neuronal System—MAPK1—ovarian cancer	5.93e-05	0.00266	CbGpPWpGaD
Disulfiram—DBH—Metabolism—ABCB1—ovarian cancer	5.56e-05	0.00249	CbGpPWpGaD
Disulfiram—DBH—Metabolism—TYMS—ovarian cancer	5.46e-05	0.00244	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—FASN—ovarian cancer	5.13e-05	0.0023	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—SLC5A5—ovarian cancer	5.05e-05	0.00226	CbGpPWpGaD
Disulfiram—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	5e-05	0.00224	CbGpPWpGaD
Disulfiram—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	4.93e-05	0.00221	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—SLC2A1—ovarian cancer	4.88e-05	0.00218	CbGpPWpGaD
Disulfiram—ALDH2—Neuronal System—HRAS—ovarian cancer	4.76e-05	0.00213	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—CYP1B1—ovarian cancer	4.68e-05	0.00209	CbGpPWpGaD
Disulfiram—DBH—Metabolism—CAV1—ovarian cancer	4.4e-05	0.00197	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—NME2—ovarian cancer	4.34e-05	0.00194	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—NME2—ovarian cancer	4.33e-05	0.00194	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—PPP2R1A—ovarian cancer	4.15e-05	0.00186	CbGpPWpGaD
Disulfiram—DBH—Metabolism—PIK3CG—ovarian cancer	4e-05	0.00179	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	3.86e-05	0.00173	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—ABCB1—ovarian cancer	3.85e-05	0.00172	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—TYMS—ovarian cancer	3.78e-05	0.00169	CbGpPWpGaD
Disulfiram—DBH—Metabolism—PIK3CD—ovarian cancer	3.52e-05	0.00158	CbGpPWpGaD
Disulfiram—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	3.3e-05	0.00148	CbGpPWpGaD
Disulfiram—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	3.25e-05	0.00146	CbGpPWpGaD
Disulfiram—DBH—Metabolism—PIK3CB—ovarian cancer	3.07e-05	0.00137	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—NME2—ovarian cancer	3.05e-05	0.00137	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—CAV1—ovarian cancer	3.05e-05	0.00137	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—CYTB—ovarian cancer	2.79e-05	0.00125	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—CYTB—ovarian cancer	2.79e-05	0.00125	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—PIK3CG—ovarian cancer	2.78e-05	0.00124	CbGpPWpGaD
Disulfiram—DBH—Metabolism—PTEN—ovarian cancer	2.65e-05	0.00119	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.59e-05	0.00116	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—PPP1CC—ovarian cancer	2.44e-05	0.00109	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—BRIP1—ovarian cancer	2.44e-05	0.00109	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—PIK3CD—ovarian cancer	2.44e-05	0.00109	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—PPP1CC—ovarian cancer	2.44e-05	0.00109	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—BRIP1—ovarian cancer	2.44e-05	0.00109	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—PIK3CB—ovarian cancer	2.13e-05	0.000953	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.11e-05	0.000945	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—NME2—ovarian cancer	2.01e-05	0.000901	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—CYTB—ovarian cancer	1.97e-05	0.00088	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.92e-05	0.00086	CbGpPWpGaD
Disulfiram—DBH—Metabolism—PIK3CA—ovarian cancer	1.87e-05	0.000838	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—PTEN—ovarian cancer	1.84e-05	0.000823	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.72e-05	0.000769	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.72e-05	0.000769	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—YAP1—ovarian cancer	1.64e-05	0.000734	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—YAP1—ovarian cancer	1.63e-05	0.000732	CbGpPWpGaD
Disulfiram—DBH—Metabolism—AKT1—ovarian cancer	1.53e-05	0.000685	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—FASN—ovarian cancer	1.34e-05	0.000598	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—FASN—ovarian cancer	1.33e-05	0.000597	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—SLC5A5—ovarian cancer	1.31e-05	0.000588	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.31e-05	0.000587	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—PIK3CA—ovarian cancer	1.3e-05	0.000581	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—CYTB—ovarian cancer	1.3e-05	0.000581	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—SLC2A1—ovarian cancer	1.27e-05	0.000568	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.27e-05	0.000567	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.25e-05	0.000561	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—CYP1B1—ovarian cancer	1.22e-05	0.000545	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—CYP1B1—ovarian cancer	1.21e-05	0.000544	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—YAP1—ovarian cancer	1.15e-05	0.000516	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.14e-05	0.000511	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.13e-05	0.000507	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.13e-05	0.000507	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	1.08e-05	0.000483	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	1.08e-05	0.000482	CbGpPWpGaD
Disulfiram—ALDH2—Metabolism—AKT1—ovarian cancer	1.06e-05	0.000474	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1e-05	0.000449	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—ABCB1—ovarian cancer	1e-05	0.000449	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—ABCB1—ovarian cancer	9.99e-06	0.000448	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—TYMS—ovarian cancer	9.83e-06	0.000441	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—TYMS—ovarian cancer	9.81e-06	0.00044	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—FASN—ovarian cancer	9.39e-06	0.000421	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—SLC5A5—ovarian cancer	9.24e-06	0.000414	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—SLC2A1—ovarian cancer	8.92e-06	0.0004	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.74e-06	0.000391	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—CYP1B1—ovarian cancer	8.55e-06	0.000383	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—CAV1—ovarian cancer	7.92e-06	0.000355	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—CAV1—ovarian cancer	7.91e-06	0.000354	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—YAP1—ovarian cancer	7.6e-06	0.00034	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	7.59e-06	0.00034	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.55e-06	0.000338	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—PIK3CG—ovarian cancer	7.22e-06	0.000323	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—PIK3CG—ovarian cancer	7.2e-06	0.000323	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—ABCB1—ovarian cancer	7.04e-06	0.000316	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—TYMS—ovarian cancer	6.92e-06	0.00031	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—PIK3CD—ovarian cancer	6.35e-06	0.000284	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—PIK3CD—ovarian cancer	6.33e-06	0.000284	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—FASN—ovarian cancer	6.19e-06	0.000277	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—SLC5A5—ovarian cancer	6.09e-06	0.000273	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.88e-06	0.000264	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5.64e-06	0.000253	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—CAV1—ovarian cancer	5.57e-06	0.00025	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—PIK3CB—ovarian cancer	5.53e-06	0.000248	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—PIK3CB—ovarian cancer	5.52e-06	0.000247	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.33e-06	0.000239	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—PIK3CG—ovarian cancer	5.08e-06	0.000227	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	5e-06	0.000224	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—PTEN—ovarian cancer	4.78e-06	0.000214	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—PTEN—ovarian cancer	4.77e-06	0.000214	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.65e-06	0.000208	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—TYMS—ovarian cancer	4.56e-06	0.000204	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—PIK3CD—ovarian cancer	4.46e-06	0.0002	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—PIK3CB—ovarian cancer	3.89e-06	0.000174	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—CAV1—ovarian cancer	3.68e-06	0.000165	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—PIK3CA—ovarian cancer	3.37e-06	0.000151	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—PIK3CA—ovarian cancer	3.36e-06	0.000151	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—PTEN—ovarian cancer	3.36e-06	0.000151	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.35e-06	0.00015	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.94e-06	0.000132	CbGpPWpGaD
Disulfiram—CYP2E1—Metabolism—AKT1—ovarian cancer	2.75e-06	0.000123	CbGpPWpGaD
Disulfiram—CYP3A5—Metabolism—AKT1—ovarian cancer	2.75e-06	0.000123	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.57e-06	0.000115	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.37e-06	0.000106	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—PTEN—ovarian cancer	2.22e-06	9.93e-05	CbGpPWpGaD
Disulfiram—CYP2C9—Metabolism—AKT1—ovarian cancer	1.94e-06	8.68e-05	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.56e-06	7.01e-05	CbGpPWpGaD
Disulfiram—CYP3A4—Metabolism—AKT1—ovarian cancer	1.28e-06	5.72e-05	CbGpPWpGaD
